Source link : https://www.newshealth.biz/health-news/big-gain-in-pfs-with-metastasis-directed-rt-for-oligometastatic-pancreatic-cancer/
Patients with oligometastatic pancreatic cancer lived more than four times longer without disease progression when they received metastasis-directed radiotherapy (RT) in addition to chemotherapy, a small randomized trial showed. Patients who received metastasis-directed therapy (MDT) had a median progression-free survival (PFS) of 10.3 months as compared with 2.5 months with chemotherapy alone. MDT was associated […]
Author : News Health
Publish date : 2024-08-07 12:52:18
Copyright for syndicated content belongs to the linked Source.
Categories